Matches in Wikidata for { <http://www.wikidata.org/entity/Q82295732> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q82295732 description "2012 թվականին հրատարակված գիտական հոդված" @default.
- Q82295732 description "artikull shkencor i botuar më 01 janar 2012" @default.
- Q82295732 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q82295732 description "im Jahr 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82295732 description "scientific article published on 01 January 2012" @default.
- Q82295732 description "wetenschappelijk artikel" @default.
- Q82295732 description "наукова стаття, опублікована в січні 2012" @default.
- Q82295732 description "научна статия" @default.
- Q82295732 name "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 name "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 name "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 type Item @default.
- Q82295732 label "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 label "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 label "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 prefLabel "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 prefLabel "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 prefLabel "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 P1433 Q82295732-8FE72724-C019-41B2-8346-03408C9AA541 @default.
- Q82295732 P1476 Q82295732-6342BCD7-CC60-4D07-AEB4-34C0E67A0146 @default.
- Q82295732 P2093 Q82295732-14C5C08B-1354-46E1-A8C6-BD1750B34CF6 @default.
- Q82295732 P2093 Q82295732-1F594105-9552-40A7-A9AE-8302E4153449 @default.
- Q82295732 P2093 Q82295732-241AA35C-7B18-4EAD-AD3A-611A2F17CBF3 @default.
- Q82295732 P2093 Q82295732-31C32B32-213A-41E2-B91F-0304D242A1B9 @default.
- Q82295732 P2093 Q82295732-3A7E4B34-AA7D-4406-864B-E0ECD113CF64 @default.
- Q82295732 P2093 Q82295732-3A8D1854-7CDA-4826-9E01-94C488F24E1A @default.
- Q82295732 P2093 Q82295732-7AD24A9F-CDF5-49C2-9B87-B61D117753A0 @default.
- Q82295732 P2093 Q82295732-9E122387-E295-4416-A677-FA0D7146DACF @default.
- Q82295732 P2093 Q82295732-FE8C7705-F0A8-452B-BD2B-F9805F4942B2 @default.
- Q82295732 P304 Q82295732-1B477AD3-105D-4250-B65D-42A8EA2707F8 @default.
- Q82295732 P31 Q82295732-B277FF12-13C5-4866-8DF4-72CCCCB429CD @default.
- Q82295732 P356 Q82295732-94A8AC57-F4E3-4AED-B150-13C571796AFE @default.
- Q82295732 P433 Q82295732-3018BC24-8A48-42B9-870D-729E1984D44B @default.
- Q82295732 P478 Q82295732-9805B3E2-0D03-49FF-BD9B-4C88E6AA0C70 @default.
- Q82295732 P577 Q82295732-F038F33B-581B-46CF-8EFA-9A0ED9F0CB4E @default.
- Q82295732 P698 Q82295732-EAE94BEB-170C-4DAF-9E16-8792D0CDA113 @default.
- Q82295732 P921 Q82295732-3B39C01F-98A3-4DE4-AF80-377189CF4851 @default.
- Q82295732 P921 Q82295732-7EBC7086-3EE3-4874-89DB-A783871EEAE9 @default.
- Q82295732 P921 Q82295732-DD18CA32-4426-4A53-8FD3-D42A557C2803 @default.
- Q82295732 P921 Q82295732-F3476B37-877E-477D-92F0-34A39B0821A6 @default.
- Q82295732 P356 FPC.0B013E32834D8376 @default.
- Q82295732 P698 22044939 @default.
- Q82295732 P1433 Q10534561 @default.
- Q82295732 P1476 "Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab" @default.
- Q82295732 P2093 "Andrea Réti" @default.
- Q82295732 P2093 "Barna Budai" @default.
- Q82295732 P2093 "Erika Hitre" @default.
- Q82295732 P2093 "István Láng" @default.
- Q82295732 P2093 "Judit Kralovánszky" @default.
- Q82295732 P2093 "Tünde Nagy" @default.
- Q82295732 P2093 "Viktor Komlósi" @default.
- Q82295732 P2093 "Vilmos Adleff" @default.
- Q82295732 P2093 "Éva Pap" @default.
- Q82295732 P304 "69-72" @default.
- Q82295732 P31 Q13442814 @default.
- Q82295732 P356 "10.1097/FPC.0B013E32834D8376" @default.
- Q82295732 P433 "1" @default.
- Q82295732 P478 "22" @default.
- Q82295732 P577 "2012-01-01T00:00:00Z" @default.
- Q82295732 P698 "22044939" @default.
- Q82295732 P921 Q108566365 @default.
- Q82295732 P921 Q188874 @default.
- Q82295732 P921 Q25493920 @default.
- Q82295732 P921 Q413299 @default.